StockNews.com Begins Coverage on Brainstorm Cell Therapeutics (NASDAQ:BCLI)
StockNews.com assumed coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Free Report) in a report released on Sunday. The firm issued a hold rating on the biotechnology company’s stock. Separately, Maxim Group upgraded shares of Brainstorm Cell Therapeutics from a hold rating to a buy rating and set a $2.00 price objective on the […]
More Stories
MAI Capital Management Sells 1,719 Shares of Vanguard Mega Cap Value ETF (NYSEARCA:MGV)
MAI Capital Management decreased its position in Vanguard Mega Cap Value ETF (NYSEARCA:MGV – Free Report) by 5.6% during the...
Recent Research Analysts’ Ratings Updates for GFL Environmental (GFL)
Several brokerages have updated their recommendations and price targets on shares of GFL Environmental (NYSE: GFL) in the last few...
S&P Global Inc. (NYSE:SPGI) Shares Sold by Wrapmanager Inc.
Wrapmanager Inc. trimmed its position in shares of S&P Global Inc. (NYSE:SPGI – Free Report) by 11.6% during the third...
Wrapmanager Inc. Buys 429 Shares of First Interstate BancSystem, Inc. (NASDAQ:FIBK)
Wrapmanager Inc. grew its position in shares of First Interstate BancSystem, Inc. (NASDAQ:FIBK – Free Report) by 5.0% during the...
AMG National Trust Bank Trims Stock Position in Expedia Group, Inc. (NASDAQ:EXPE)
AMG National Trust Bank cut its stake in Expedia Group, Inc. (NASDAQ:EXPE – Free Report) by 26.2% in the 3rd...
Fifth Third Wealth Advisors LLC Invests $1.72 Million in NVR, Inc. (NYSE:NVR)
Fifth Third Wealth Advisors LLC purchased a new stake in shares of NVR, Inc. (NYSE:NVR – Free Report) in the...